Ms. Drexler brings technical/engineering capabilities, coupled with business vision and entrepreneurial experience, to the executive suite and the boardroom. She has been an active board member for public and private medical device and diagnostics companies for over a decade. She currently sits on the boards of ResMed (RSMD: NYSE), Outset Medical (Nasdaq: OM), Tivic Health (Nasdaq), VIDA Diagnostics, Huma.ai, and EBR Systems (ASX).
Ms. Drexler also has extensive management experience. She founded and ran Amira Medical until its sale to Roche Diabetes Care. She managed a variety of functions across the company at LifeScan and executed the sale of the company to Johnson & Johnson. Most recently, Ms. Drexler was the CEO of Sandstone Diagnostics, a life science tools company focused on increasing access to high-quality diagnostic testing, which was sold to LabCorp.
Ms. Drexler was named Female Entrepreneur of the Year by the Stevie Awards in 2013 and Entrepreneurial Woman of the Year by the Silicon Valley Women’s Fund in 2002. She was also named Director of the Year in 2018 by Women’s Inc. Magazine.
In addition to her corporate board roles, Ms. Drexler is active in Astia (www.astia.com) and Springboard (www.sb.co), nonprofit organizations that support female entrepreneurs. She is a Founding Member of Astia Angels.
A Guest Lecturer at Stanford University in Medical Device Design and Mobile Health curricula, Ms. Drexler also provides team support and mentoring for the Stanford Biodesign Fellowship and StartX, an off-campus Stanford accelerator.
A native of New Jersey, Ms. Drexler received her MBA from Stanford University and her BSE in Chemical Engineering from Princeton University. She and her husband Andy, a fellow Stanford MBA, reside in the San Francisco Bay Area.
